There are different options for getting your patients started on treatment once a prescribing decision has been made.
Acquire HyQvia directly for infusion in your clinic
The details below can help ensure your patients are equipped with everything they need for an optimal administration experience.
The HyQvia dose is based on the IG component, which provides the therapeutic effect. Increased dispersion and absorption of IG into the bloodstream is facilitated by the Recombinant Human Hyaluronidase.
HyQvia initial monthly* dosing (following ramp-up) may vary depending on whether patients are switching from intravenous immune globulin (IVIG) treatment or conventional SCIG treatment.
*Every 3 or 4 weeks.
The following presentations of HyQvia are available1:
|Immune Globulin Infusion 10% (Human)||Recombinant Human Hyaluronidase|
|0944-2510-02||25 mL||2.5||1.25 mL||200|
|0944-2511-02||50 mL||5.0||2.5 mL||400|
|0944-2512-02||100 mL||10.0||5.0 mL||800|
|0944-2513-02||200 mL||20.0||10.0 mL||1600|
|0944-2514-02||300 mL||30.0||15.0 mL||2400|
|Immune Globulin Infusion 10% (Human)|
|Recombinant Human Hyaluronidase|
When getting started on therapy, your patients will receive HyQvia from a specialty pharmacy provider (SPP). Here are some considerations when working with an SPP:
Is HyQvia covered under the pharmacy or medical benefit? This will impact how your office acquires HyQvia and is reimbursed
Check the patient's health plan to see which SPPs are covered (see authorized list below)
Avoid substitution by having the healthcare provider specify "dispense as written" (DAW) on the HyQvia prescription
If the SPP form doesn't have HyQvia listed, clearly write it on the form
Confirm that the appropriate tubing, ancillaries, and/or accompanying medications are dispensed alongside HyQvia
Find an authorized HyQvia SPP
Patients prescribed HyQvia may receive It from an SPP. Check your patient’s insurance coverage to determine which SPP is within your patient’s network.
The following SPPs are authorized to dispense HyQvia:
Inquire with specific SPPs for current status.
All product brands or trademarks are the property of their respective owners.